New medical advances could revolutionise the ability to treat undetected tuberculosis (TB) thanks to an international team of scientists led by the University of St Andrews.
MBLA Conference
the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
MBLA Conference
Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.
Partnership to strengthen Research ethics and Medicines regulation in Tanzania
The University of St Andrews in partnership with NIMR, TFDA and KCRI launched the SMERT (Streamlining health research ethics and medicines regulation) project on 23rd April 2018 in Dar es Salaam, the capital of Tanzania.
Keystone Symposia on Translating tuberculosis research findings into policy and practice
Dr. Wilber Sabiiti recently presented a paper at the Keystone Symposia on Translation of tuberculosis research into policy and practice.
The Molecular bacterial load assay at Public Health England (PHE), Porton Down, Salisbury
Dr. Wilber Sabiiti spent several days with the Porton Down PHE tuberculosis (TB) research team training them and optimising their Real-time PCR platform QuantiStudio TM Vii 6 and 7 Flex to perform Molecular bacterial load assay (MBLA).
The TWENDE course in Uganda: Translating Research Evidence into solutions
Dr Wilber Sabiiti and Dr Ewan Chrinside recently ran training sessions on translating research knowledge into commercial products and policies to practice at the recent TWENDE Course in Uganda.
The Union Africa Regional Conference on Tuberculosis and Lung diseases
Dr. Wilber Sabiiti recently presented some of his work at the UARC-TLD.
The Antimicrobial agents’ usage, antimicrobial resistance and policy symposium
Hosted as part of the 6th East African Health and Scientific Research Conference and International trade fair the symposium was co-chaired by Dr. Wilber Sabiiti and Dr. Helen Meme of Kenya Medical Research Institute (KEMRI).
Getting innovative diagnostic and treatment tools into policy and practice
Dr Wilber Sabiiti has recently given a series of talks and training in different African countries showcasing the advantages of the molecular bacterial load assay (MBLA) and TWENDE work on developing model for rapid uptake of health research innovations into policy and practice.
- Page 1 of 2
- 1
- 2